Almirall, S.A. (OTCMKTS:LBTSF – Get Free Report) shares fell 3.5% during mid-day trading on Friday . The stock traded as low as $9.17 and last traded at $9.17. 312 shares were traded during mid-day trading, an increase of 56% from the average session volume of 200 shares. The stock had previously closed at $9.51.
Almirall Stock Performance
The stock has a 50-day moving average price of $9.51 and a 200 day moving average price of $9.51.
About Almirall
Almirall, SA, a biopharmaceutical company, engages in the purchase, manufacture, storage, and sale of skin-health medicines in Europe, the Middle East, the United States, Asia, and Africa. The company offers its products for skin diseases comprising actinic keratosis, atopic dermatitis, alopecia areata, skin cancer, psoriasis, onychomycosis, vitiligo, hidradenitis suppurativa, oncodermatology, acne, orphan indications, and rare skin diseases, as well as for alimentary tract and metabolism; antiinfectives for systemic use; cardiovascular, musculo-skeletal, respiratory, and nervous system; dermatologicals; genito urinary system and sex hormones; immunostimulants; and systematic hormonal preparations.
Read More
- Five stocks we like better than Almirall
- What is the S&P/TSX Index?
- Disney’s Magic Strategy: Reinventing the House of Mouse
- Investing In Preferred Stock vs. Common Stock
- Volatility in Semis? 3 Stable Alternatives to NVIDIA and SMCI
- Why Invest in 5G? How to Invest in 5G Stocks
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
Receive News & Ratings for Almirall Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Almirall and related companies with MarketBeat.com's FREE daily email newsletter.
